Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients

NCT01121120 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin
Hodgkin Disease
Multiple Myeloma

Interventions

DRUG: TXA127
DRUG: Placebo

Sponsor

Tarix Pharmaceuticals

Collaborators

[object Object]